Note
|
June 30, 2019
|
December 31, 2018
|
||||||||||
Assets
|
||||||||||||
Current Assets:
|
||||||||||||
Cash and cash equivalents
|
$
|
10,320,183
|
$
|
11,471,243
|
||||||||
Amounts receivable
|
55,208
|
143,225
|
||||||||||
Deposits
|
7
|
8,864,346
|
8,541,630
|
|||||||||
Prepaid expense
|
635,212
|
586,581
|
||||||||||
Total Current Assets
|
$
|
19,874,949
|
$
|
20,742,679
|
||||||||
Patent Rights
|
3
|
1,337,975
|
1,172,485
|
|||||||||
Total Assets
|
$
|
21,212,924
|
$
|
21,915,164
|
||||||||
Liabilities
|
||||||||||||
Current Liabilities:
|
||||||||||||
Accounts payable and accrued liabilities
|
4
|
$
|
12,231,777
|
$
|
6,447,888
|
|||||||
Warrant liability
|
2b, 5
|
27,307,700
|
11,250,167
|
|||||||||
Total Liabilities
|
$
|
39,539,477
|
$
|
17,698,055
|
||||||||
Shareholders' Equity (Deficiency)
|
||||||||||||
Share Capital
|
6
|
$
|
189,723,070
|
$
|
170,502,394
|
|||||||
Contributed Surplus
|
7,643,817
|
6,652,409
|
||||||||||
Deficit
|
(215,693,440
|
)
|
(172,937,694
|
)
|
||||||||
Total Equity / (Deficiency)
|
$
|
(18,326,553
|
)
|
$
|
4,217,109
|
|||||||
Total Liabilities and Equity / (Deficiency)
|
$
|
21,212,924
|
$
|
21,915,164
|
Commitments (Note 7)
|
||
See notes to financial statements
|
||
Approved on behalf of the Board:
|
||
"signed"
|
"signed"
|
|
Charles Federico
|
David McNally
|
|
Chairman
|
President and CEO
|
Share Capital
|
Contributed
|
Total
|
||||||||||||||||||||||||||
Note
|
Number
|
Amount
|
Surplus
|
Warrants
|
Deficit
|
Equity
|
||||||||||||||||||||||
Balance - December 31, 2017
|
12,686,723
|
$
|
154,016,519
|
$
|
5,146,784
|
$
|
741,917
|
$
|
(150,298,422
|
)
|
$
|
9,606,798
|
||||||||||||||||
Issued pursuant to agency agreement
|
1,295,552
|
4,013,710
|
-
|
-
|
-
|
4,013,710
|
||||||||||||||||||||||
Share issue expense
|
(399,107
|
)
|
-
|
-
|
-
|
(399,107
|
)
|
|||||||||||||||||||||
Issued for Services
|
7,500
|
66,234
|
-
|
-
|
-
|
66,234
|
||||||||||||||||||||||
Warrants exercised during the period
|
6,500
|
59,998
|
-
|
-
|
-
|
59,998
|
||||||||||||||||||||||
Warrants expired during the period
|
-
|
741,917
|
-
|
(741,917
|
)
|
-
|
-
|
|||||||||||||||||||||
Stock based compensation
|
-
|
-
|
723,405
|
-
|
-
|
723,405
|
||||||||||||||||||||||
Net and Comprehensive loss
|
-
|
-
|
-
|
-
|
(6,694,114
|
)
|
(6,694,114
|
)
|
||||||||||||||||||||
Balance - June 30, 2018
|
13,996,275
|
$
|
158,499,271
|
$
|
5,870,189
|
$
|
-
|
$
|
(156,992,536
|
)
|
$
|
7,376,924
|
||||||||||||||||
Balance - December 31, 2018
|
21,675,849
|
$
|
170,502,394
|
$
|
6,652,409
|
$
|
-
|
$
|
(172,937,694
|
)
|
$
|
4,217,109
|
||||||||||||||||
Issued pursuant to agency agreement
|
6a
|
|
8,455,882
|
13,717,131
|
-
|
-
|
-
|
13,717,131
|
||||||||||||||||||||
Share issue expense
|
(1,498,498
|
)
|
-
|
-
|
-
|
(1,498,498
|
)
|
|||||||||||||||||||||
Warrants exercised during the period
|
6a
|
|
1,018,506
|
7,002,043
|
-
|
-
|
7,002,043
|
|||||||||||||||||||||
Stock based compensation
|
6b
|
|
-
|
-
|
991,408
|
-
|
-
|
991,408
|
||||||||||||||||||||
Net and Comprehensive loss
|
-
|
-
|
-
|
-
|
(42,755,746
|
)
|
(42,755,746
|
)
|
||||||||||||||||||||
Balance - June 30, 2019
|
31,150,237
|
$
|
189,723,070
|
$
|
7,643,817
|
$
|
-
|
$
|
(215,693,440
|
)
|
$
|
(18,326,553
|
)
|
|||||||||||||||
See notes to financial statements
|
Three Months Ended
|
Six Months Ended
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||
Note
|
June 30, 2019
|
June 30, 2019
|
June 30, 2018
|
June 30, 2018
|
||||||||||||||||
Revenue:
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||||||||
Expenses:
|
||||||||||||||||||||
Amortization
|
$
|
7,291
|
$
|
13,466
|
$
|
5,372
|
$
|
17,114
|
||||||||||||
Consulting fees
|
451,068
|
720,497
|
141,076
|
371,188
|
||||||||||||||||
Stock based compensation
|
6b
|
|
740,051
|
991,408
|
356,348
|
723,405
|
||||||||||||||
Insurance
|
116,123
|
234,612
|
6,900
|
15,957
|
||||||||||||||||
Management salaries and fees
|
749,880
|
1,398,466
|
730,975
|
1,439,999
|
||||||||||||||||
Marketing and investor relations
|
102,487
|
208,676
|
126,381
|
170,998
|
||||||||||||||||
Office and general
|
77,136
|
194,407
|
128,453
|
234,627
|
||||||||||||||||
Professional fees
|
303,460
|
406,845
|
178,687
|
324,467
|
||||||||||||||||
Rent
|
16,515
|
28,751
|
24,999
|
49,793
|
||||||||||||||||
Research and Development
|
18,360,674
|
32,769,286
|
6,246,275
|
9,520,349
|
||||||||||||||||
Travel
|
80,631
|
147,995
|
113,610
|
185,897
|
||||||||||||||||
Foreign exchange (gain)/loss
|
148,689
|
41,047
|
(417,244
|
)
|
(932,397
|
)
|
||||||||||||||
$
|
21,154,005
|
$
|
37,155,456
|
$
|
7,641,832
|
$
|
12,121,397
|
|||||||||||||
Finance Income (cost):
|
||||||||||||||||||||
Interest
|
$
|
71,187
|
$
|
94,218
|
$
|
54,691
|
$
|
82,983
|
||||||||||||
Gain (Loss) on change in fair value of warrants
|
2b, 5
|
6,609,952
|
(3,866,673
|
)
|
2,210,537
|
5,853,111
|
||||||||||||||
Warrant liability issue cost
|
-
|
(1,827,835
|
)
|
(508,811
|
)
|
(508,811
|
)
|
|||||||||||||
$
|
6,681,139
|
$
|
(5,600,290
|
)
|
$
|
1,756,417
|
$
|
5,427,283
|
||||||||||||
Net and Comprehensive Loss For The Year
|
$
|
14,472,866
|
$
|
42,755,746
|
$
|
5,885,415
|
$
|
6,694,114
|
||||||||||||
Basic and Diluted Loss Per Share
|
$
|
0.46
|
$
|
1.57
|
$
|
0.43
|
$
|
0.50
|
||||||||||||
Weighted Average Number of Common Shares,
|
||||||||||||||||||||
Basic and Diluted
|
31,150,237
|
27,190,063
|
13,798,229
|
13,250,357
|
||||||||||||||||
See notes to financial statements
|
Three Months Ended
|
Six Months Ended
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||
June 30, 2019
|
June 30, 2019
|
June 30, 2018
|
June 30, 2018
|
|||||||||||||
Cash provided by (used in):
|
||||||||||||||||
Operating activities:
|
||||||||||||||||
Net loss for the period
|
$
|
(14,472,866
|
)
|
$
|
(42,755,746
|
)
|
$
|
(5,885,415
|
)
|
$
|
(6,694,114
|
)
|
||||
Items not involving cash:
|
||||||||||||||||
Amortization
|
7,291
|
13,466
|
5,372
|
17,114
|
||||||||||||
Stock based compensation
|
740,051
|
991,408
|
356,348
|
723,405
|
||||||||||||
Other share compensation
|
-
|
-
|
-
|
66,234
|
||||||||||||
Warrant liability-fair value adjustment
|
(6,609,952
|
)
|
3,866,673
|
(2,210,537
|
)
|
(5,853,111
|
)
|
|||||||||
Warrant liability-foreign exchange adjustment
|
142,682
|
36,625
|
(421,301
|
)
|
(935,656
|
)
|
||||||||||
Changes in non-cash working capital items:
|
||||||||||||||||
Amounts receivable, prepaid expenses and deposits
|
1,294,599
|
(283,330
|
)
|
(10,120
|
)
|
(1,818,430
|
)
|
|||||||||
Accounts payable and accrued liabilities
|
5,736,133
|
5,783,889
|
1,274,644
|
1,970,483
|
||||||||||||
Cash used in operating activities
|
$
|
(13,162,062
|
)
|
$
|
(32,347,015
|
)
|
$
|
(6,891,009
|
)
|
$
|
(12,524,075
|
)
|
||||
Financing activities:
|
||||||||||||||||
Net proceeds from issuance of common shares and warrants
|
(2,997
|
)
|
31,374,911
|
8,828,240
|
8,857,740
|
|||||||||||
Cash provided by financing activities
|
$
|
(2,997
|
)
|
$
|
31,374,911
|
$
|
8,828,240
|
$
|
8,857,740
|
|||||||
Investing Activities:
|
||||||||||||||||
Cost of Patents
|
(125,198
|
)
|
(178,956
|
)
|
(40,491
|
)
|
(97,039
|
)
|
||||||||
Cash used in investing activities
|
$
|
(125,198
|
)
|
$
|
(178,956
|
)
|
$
|
(40,491
|
)
|
$
|
(97,039
|
)
|
||||
Increase (Decrease) in cash and cash equivalents
|
(13,290,257
|
)
|
(1,151,060
|
)
|
1,896,740
|
(3,763,374
|
)
|
|||||||||
Cash and cash equivalents, beginning of the period
|
23,610,440
|
11,471,243
|
20,470,379
|
26,130,493
|
||||||||||||
Cash and cash equivalents, end of the period
|
$
|
10,320,183
|
$
|
10,320,183
|
$
|
22,367,119
|
$
|
22,367,119
|
||||||||
Cash and cash equivalents comprise:
|
||||||||||||||||
Cash
|
$
|
1,392,741
|
$
|
1,392,741
|
$
|
134,243
|
$
|
134,243
|
||||||||
Cash Equivalents
|
8,927,442
|
8,927,442
|
22,232,876
|
22,232,876
|
||||||||||||
$
|
10,320,183
|
$
|
10,320,183
|
$
|
22,367,119
|
$
|
22,367,119
|
|||||||||
See notes to financial statements
|
1.
|
DESCRIPTION OF BUSINESS
|
(a)
|
Statement of Compliance
|
(b)
|
Basis of Measurement
|
(c)
|
Functional and Presentation Currency
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
(a)
|
Use of Estimates and Judgements
|
(b)
|
Warrant Liability
|
(c)
|
Fair Value Measurement
|
(d)
|
Adoption of New Accounting Standard
|
3.
|
PATENT RIGHTS
|
For the six months ended June 30, 2019
|
Cost
|
Accumulated Amortization & Impairment Losses
|
Net Book Value
|
|||||||||
Balance at December 31, 2018
|
1,398,713
|
(226,228
|
)
|
1,172,485
|
||||||||
Additions during the period
|
178,956
|
-
|
178,956
|
|||||||||
Amortization in the period
|
-
|
(13,466
|
)
|
(13,466
|
)
|
|||||||
Balance at June 30, 2019
|
1,577,669
|
(239,694
|
)
|
1,337,975
|
4.
|
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
|
Six Months Ended
June 30, 2019
|
Year Ended
December 31, 2018
|
|||||||||||||||
Number of Warrants
|
Amount
|
Number of Warrants
|
Amount
|
|||||||||||||
Opening Balance
|
13,901,859
|
$
|
11,250,167
|
4,933,231
|
$
|
17,849,460
|
||||||||||
Issue of warrants expiring, April 10, 2023
|
-
|
-
|
1,295,554
|
5,212,087
|
||||||||||||
Issue of warrants expiring, August 10, 2023
|
-
|
-
|
7,679,574
|
6,297,251
|
||||||||||||
Issue of warrants expiring, March 21, 2024
|
8,455,882
|
15,897,059
|
-
|
-
|
||||||||||||
Warrants exercised during the period
|
(1,018,506
|
)
|
(3,742,824
|
)
|
(6,500
|
)
|
(28,949
|
)
|
||||||||
Warrants expired during the period
|
(135,824
|
)
|
-
|
-
|
-
|
|||||||||||
Foreign exhange adjustment during the period
|
-
|
36,625
|
-
|
(984,462
|
)
|
|||||||||||
Fair value adjustment during the period
|
-
|
3,866,673
|
-
|
(17,095,220
|
)
|
|||||||||||
Ending Balance
|
21,203,411
|
$
|
27,307,700
|
13,901,859
|
$
|
11,250,167
|
a)
|
Authorized:
|
unlimited number of common shares, no par
|
|
|
|
|
Issued:
|
31,150,237 (December 31, 2018: 21,675,849)
|
May 29, 2019 before the amendments
|
May 29, 2019 after the amendments
|
||||
Fair Value at grant
|
CDN $0.01-$1.40
|
CDN $1.06-$2.10
|
|||
Share price at grant
|
CDN $3.47
|
CDN $3.47
|
|||
Exercise price
|
CDN $12.90-$51.60
|
CDN $4.54
|
|||
Expected Volatility
|
98.6%-99.4%
|
98.6%-99.4%
|
|||
Expected Option Life
|
1.0-3.5 years
|
1.0-3.5 years
|
|||
Expected dividends
|
Nil
|
Nil
|
|||
Risk free interest rate (based on government bonds)
|
1.48%-1.57%
|
1.48%-1.57%
|
Six Months ended
June 30, 2019
|
Year ended
December 31, 2018
|
|||
Number of Stock Options
|
Weighted average
Exercise Price (CDN)
|
Number of Stock Options
|
Weighted average
Exercise Price (CDN)
|
|
Balance Beginning
|
875,433
|
$ 18.20
|
591,609
|
$ 21.30
|
Granted
|
10,000
|
$ 4.54
|
322,517
|
$ 13.51
|
Expired/Forfeited
|
(41,745)
|
$ 31.29
|
(38,693)
|
$ 24.90
|
Balance Ending
|
843,688
|
$ 6.23
|
875,433
|
$ 18.20
|
Six Months ended
June 30, 2019
|
Year ended
December 31, 2018
|
|||
Number of Stock Options
|
Weighted average
Exercise Price (USD)
|
Number of Stock Options
|
Weighted average
Exercise Price (USD)
|
|
Balance Beginning
|
50,349
|
$ 1.55
|
-
|
-
|
Granted 2
|
293,000
|
$ 3.44
|
50,349
|
$ 1.55
|
Expired/Forfeited
|
-
|
-
|
-
|
-
|
Balance Ending
|
343,349
|
$ 3.17
|
50,349
|
$ 1.55
|
1.
|
After giving consideration for 30:1 share consolidation effected June 2018.
|
2.
|
Options granted in the period ending June 30, 2019 will vest in accordance with vesting schedules and milestones over a period up to 7 years.
|
Canadian Dollar Denominated Options
|
||||||||||||
Exercise Price (CDN)
|
Number
Outstanding
|
Weighted-average remaining contractual life (years)
|
Options
Exercisable
|
|||||||||
$3.28
|
31,498
|
6.17
|
31,498
|
|||||||||
$4.50
|
18,936
|
3.78
|
18,936
|
|||||||||
$4.54
|
717,402
|
4.65
|
245,831
|
|||||||||
$4.80
|
3,040
|
1.21
|
3,040
|
|||||||||
$7.49
|
5,590
|
6.02
|
5,590
|
|||||||||
$9.00
|
11,481
|
6.02
|
11,481
|
|||||||||
$9.60
|
1,105
|
1.27
|
1,105
|
|||||||||
$11.70
|
6,667
|
1.44
|
6,667
|
|||||||||
$12.00
|
1,948
|
1.43
|
1,948
|
|||||||||
$30.00
|
34,777
|
2.15
|
23,185
|
|||||||||
$30.60
|
2,625
|
1.48
|
2,625
|
|||||||||
$32.40
|
810
|
1.58
|
810
|
|||||||||
$41.70
|
658
|
0.46
|
658
|
|||||||||
$45.30
|
560
|
1.12
|
560
|
|||||||||
$51.60
|
6,592
|
0.95
|
6,592
|
|||||||||
843,689
|
4.52
|
360,526
|
||||||||||
US Dollar Denominated Options
|
||||||||||||
Exercise Price (USD)
|
Number
Outstanding
|
Weighted-average remaining contractual life (years)
|
Options
Exercisable
|
|||||||||
$1.55
|
50,349
|
2.47
|
50,349
|
|||||||||
$3.72
|
40,000
|
2.63
|
-
|
|||||||||
$3.40
|
253,000
|
6.84
|
156,000
|
|||||||||
343,349
|
5.71
|
206,349
|
Grant date/ Recipient
|
Number of Options 1
|
Vesting Conditions
|
Contractual Life of Options
|
February 14, 2019, options granted to a Consultant
|
40,000
|
Options may vest over a 15-month vesting schedule
|
3 years
|
May 29, 2019, options granted to a Director
|
253,000
|
Options vest over a specified vesting period not exceeding 4 years
|
7 years
|
June 28, 2019, options granted to an Employee
|
10,000
|
Options vest as to 1/3 of the total number of Options granted, every year from Option Date
|
7 years
|
2019
|
2018
|
|||||
Fair Value at grant
|
US $1.76
|
CDN $5.99
|
||||
Share price at grant
|
US $2.84
|
CDN $10.79
|
||||
Exercise price
|
US $3.40
|
CDN $11.97
|
||||
Expected Volatility
|
98.43%
|
90.12%
|
||||
Expected Option Life
|
3.5 years
|
3 years
|
||||
Expected dividends
|
Nil
|
Nil
|
||||
Risk free interest rate (based on government bonds)
|
1.61%
|
1.90%
|
June 30, 2019
|
December 31, 2018
|
|||||||||||||||
Number of Shares
|
%
|
Number of Shares
|
%
|
|||||||||||||
John Barker
|
32,714
|
0.11
|
31,714
|
0.15
|
||||||||||||
Stephen Randall
|
22,993
|
0.07
|
21,643
|
0.10
|
||||||||||||
David McNally
|
4,167
|
0.01
|
4,167
|
0.02
|
||||||||||||
Bruce Wolff 1
|
-
|
-
|
7,610
|
0.03
|
||||||||||||
John Schellhorn
|
294
|
0.00
|
294
|
0.00
|
||||||||||||
Total
|
60,168
|
0.19
|
65,428
|
0.30
|
||||||||||||
Common Shares Outstanding
|
31,150,237
|
100
|
%
|
21,675,849
|
100
|
%
|
||||||||||
1: Bruce Wolff retired as a Director effective May 29, 2019
|